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Introduction: Calibrated arterial pulse contour analysis has become an established method for the continuous
monitoring of cardiac output (PCCO). However, data on its validity in hemodynamically instable patients beyond
the setting of cardiac surgery are scarce. We performed the present study to assess the validity and precision of
PCCO-measurements using the PiCCO™-device compared to transpulmonary thermodilution derived cardiac output
(TPCO) as the reference technique in neurosurgical patients requiring high-dose vasopressor-therapy.
Methods: A total of 20 patients (16 females and 4 males) were included in this prospective observational clinical
trial. All of them suffered from subarachnoid hemorrhage (Hunt&Hess grade I-V) due to rupture of a cerebral arterial
aneurysm and underwent high-dose vasopressor therapy for the prevention/treatment of delayed cerebral ischemia
(DCI). Simultaneous CO measurements by bolus TPCO and PCCO were obtained at baseline as well as 2 h, 6 h,
12 h, 24 h, 48 h and 72 h after inclusion.
Results: PCCO- and TPCO-measurements were obtained at baseline as well as 2 h, 6 h, 12 h, 24 h, 48 h and 72 h after
inclusion. Patients received vasoactive support with (mean ± standard deviation, SD) 0.57 ± 0.49 μg · kg-1 · min-1 norepinephrine
resulting in a mean arterial pressure of 103 ± 13 mmHg and a systemic vascular resistance of 943 ± 248 dyn · s · cm-5. 136
CO-data pairs were analyzed. TPCO ranged from 5.2 to 14.3 l · min-1 (mean± SD 8.5 ± 2.0 l · min-1) and PCCO ranged from 5.0
to 14.4 l · min-1 (mean ± SD 8.6 ± 2.0 l · min-1). Bias and limits of agreement (1.96 SD of the bias) were −0.03 ± 0.82 l · min-1 and
1.62 l · min-1, resulting in an overall percentage error of 18.8%. The precision of PCCO-measurements was 17.8%. Insufficient
trending ability was indicated by concordance rates of 74% (exclusion zone of 15% (1.29 l · min-1)) and 67% (without exclusion
zone), as well as by polar plot analysis.
Conclusions: In neurosurgical patients requiring extensive vasoactive support, CO values obtained by calibrated PCCO
showed clinically and statistically acceptable agreement with TPCO-measurements, but the results from concordance and
polar plot analysis indicate an unreliable trending ability.Introduction
Pulmonary arterial thermodilution has long been consid-
ered the clinical gold standard for the measurement of
cardiac output (CO). Concerns about the inherent risks of
pulmonary artery catheterization have driven the develop-
ment of less invasive devices for monitoring CO [1] of* Correspondence: steffen.rex@gmail.com
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reproduction in any medium, provided the orwhich calibrated arterial pulse-contour analysis (PCCO) as
implemented in the PiCCO™-device (Pulsion Medical Sys-
tems, Munich, Germany) has become increasingly popular
[2]. Meanwhile, the accuracy of pulse-contour derived car-
diac output (PCCO) measurements has been tested in a
variety of validation studies [3-9]. However, these studies
are subject to different limitations. First, the vast majority
of validation studies has been performed in cardiac surgi-
cal patients receiving if any, only minimal-to-moderate
pharmacological hemodynamic support [3-5,9]. Hence,ral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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monitoring in situations with significant hemodynamic in-
stability and in settings not related to cardiac surgery. Sec-
ond, most of the studies assessed the validity of PCCO
measurements by analyzing the correlation, bias and the
limits of agreement with the chosen reference method
[10]. In contrast, the percentage error as an important
statistical measure was only reported in a minority of val-
idation studies [11]. Moreover, as the total percentage
error is a composite of both the tested and the reference
method, a true interpretation of validation studies is only
possible if the precision of the PCCO technique and the
reference method is described separately [12]. To the best
of our knowledge, the precision of PCCO measurements
has not yet been reported [7,8].
Furthermore, only a minority of validation studies ad-
dressed CO trending, with few investigators reporting
concordance rates as an indicator of reliable trending
detection [13-15]. No data exist, however, analyzing the
concordance between PCCO measurements and a refer-
ence method. Recently Critchley et al. suggested polar-
plot analysis as the most valid method to assess trending
ability [16], and this statistical technique has not yet
been applied to PCCO measurements.
In the present study therefore, we analyzed the validity
of PCCO measurements by comparison with intermit-
tent transpulmonary thermodilution CO (TPCO) mea-
surements. The study was performed in neurosurgical
patients who, following the actual guidelines for the
treatment of delayed cerebral ischemia (DCI) subsequent
to subarachnoid hemorrhage (SAH), were treated with
extensive vasoactive support (evidence level: Class I,
Level B) [17,18]. In the presence of vasoconstriction,
pulse-contour analysis has been recently reported to ex-
hibit insufficient accuracy [19-22]. For the analysis of the
agreement with the reference method, we employed the
current statistical gold-standard methods, including the
separate quantification of the precision of both the
PCCO and the TPCO measurements. To investigate the
trending ability of PCCO we determined the concord-
ance as recently suggested by Perrino et al. [23,24] and
additionally employed the polar-plot technique [16].
Materials and methods
Patients
After approval by the institutional review board (Ethik-
Kommission an der Medizinischen Fakultät der Rheinisch-
Westfälischen Technischen Hochschule Aachen, EK 171/
07) and obtainment of written informed consent by either
the patient or legal representative, 20 consecutive patients
(16 female and 4 male) were included in this study. The
trial was not registered because it was observational and
not randomized. All of these patients were simultaneously
included in another observational study with a similarstudy design, comparing the validity of arterial pressure
waveform analysis of cardiac output using the FloTrac/
Vigileo™-device with TPCO [25]. Patients <18 years of age,
pregnant patients, patients from whom written informed
consent could not be obtained and patients with occlusive
peripheral arterial disease were excluded from the study.
All patients suffered from SAH (Hunt and Hess grade I-V)
due to rupture of a cerebral arterial aneurysm and subse-
quent development of cerebral arterial vasospasms. Hyper-
tension induced by high-dose vasopressor support was
initiated after the cerebral aneurysm had been interven-
tionally coiled (five patients) or surgically clipped (fifteen
patients).
Patient management
Systemic arterial hypertension was induced by an infu-
sion of norepinephrine to achieve a systolic arterial pres-
sure of approximately 140 to 220 mmHg, resulting in
mean arterial pressure (MAP) >100 mmHg and cerebral
perfusion pressure (CPP) >80 mmHg (CPP =MAP –
intracranial pressure (ICP)) [26]. In addition, all patients
underwent a continuous infusion of nimodipine (2 mg·h-1).
In the event of hemodynamic instability and excessive need
of cardiovascular support, the dosage of nimodipine was
reduced.
Hemodynamic monitoring
Routine hemodynamic variables were recorded continu-
ously (Agilent Technologies, Böblingen, Germany). As
part of our standard monitoring in these patients, a 5-F
thermistor-tipped catheter (PV2015L20A, Pulsiocath, Pul-
sion Medical Systems, Munich, Germany) was inserted
into the femoral artery. In order to monitor and optimize
hemodynamic therapy, CO and intrathoracic blood vol-
ume (ITBV) were measured by means of intermittent
TPCO (PiCCOplus V 5.2.2, Pulsion Medical Systems)
[27]. Indicator dilution measurements were performed by
quadruple bolus injections of 20 ml of ice-cooled saline
0.9% into the right atrium.
In addition, CO was continuously monitored using ar-
terial pulse wave contour analysis. Pulse-contour analysis
was calibrated with transpulmonary thermodilution at
predefined time intervals (see below), allowing the calcu-










where HR = heart rate; cal = individual calibration factor
assessed by transpulmonary thermodilution; P tð ÞSVR = area
under the pressure curve; C(p) = aortic compliance, and
dP
dt = shape of the pressure curve.
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After inclusion of the patients into the study, hemodynamic
parameters were assessed at the following time points: in-
clusion (T0), 2 hours (T2), 6 hours (T6), 12 hours (T12),
24 hours (T24), 48 hours (T48) and 72 hours (T72). These
time points also served to recalibrate PCCO measurements
with transpulmonary thermodilution. Of note, only PCCO
values recorded immediately prior to recalibration of pulse-
contour analysis were included in the analysis of validity.
Statistical analysis
Statistical analysis was performed using Sigma Plot (SigmaPlot®
for Windows Version 11.0; Systat Software Inc. Chicago, US).
All data are expressed asmean± SDunless indicated otherwise.
After testing for normal distribution using the Shapiro-Wilk
test, normally distributed hemodynamic variables were com-
pared with baseline by analysis of variance (ANOVA) for
repeatedmeasurements [28,29]. Non-normally distributed data
(CVP, ITBV and vasopressor doses) were analyzed using
FriedmanANOVA. If the analysis of variance revealed a signifi-
cant interaction, post hoc analysis and correction for multiple
comparisons were performed using the Tukey honest signifi-
cant difference (HSD) test.
Linear regression analysis was used to describe the rela-
tionship between TPCO and PCCO measurements, both
for absolute values and for percentage changes in CO, as
well as for the dependency of PCCO measurements from
systemic vascular resistance (SVR).
Bias and limits of agreement were calculated according to
Bland and Altman [10] and adjusted for repeated measure-
ments assuming a non-constant situation according to the
procedure originally described by Bland and Altman [30].
Bias was defined as the mean difference between TPCO
and PCCO values and the limits of agreement were calcu-
lated as the bias ± 1.96 SD: 95% of the differences between
the two methods were expected to lie within this range.
According to Critchley and Critchley, for comparison of
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of the quadruple TPCO measurements for each time-
point as suggested by Cecconi et al. [12]. Therefore, theprecision of the PCCO measurements was determined
using the following equations [12]:
CVTPCO−PCCO ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
CVTPCOð Þ2 þ CVPCCOð Þ2
 q ð3Þ
where
CVTPCO-PCCO = CV of the distinctions between the two
methods;
CVTPCO = CV of TPCO measurements;
CVPCCO = CV of PCCO measurements,
as:
PrecisionTPCO = precision for the reference method = 2
CETPCO
PrecisionPCCO = precision for PCCO = 2 CVPCCO
PETPCO-PCCO = Percentage error known from the










PETPCO−PCCOð Þ− PrecisionTPCOð Þ2
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ð5Þ
According to the recommendations originally proposed
by Critchley and Critchley [11] the acceptance of the
PCCO method is to be judged against the ± 10 to 20%
accuracy of the reference method (that is, TPCO). Con-
sequently, limits of agreement between PCCO and TPCO
of <30% are to be accepted.
Two consecutive measurements using the same method
offer the possibility to quantify the absolute and percent-
age change within the measured parameter, here, ΔCO.
To assess the reliability of trending detection of the test
method compared with the reference method, we used
the method first described by Perrino et al. in 1994, that
is, based on regression analysis, direction of change statis-
tics and concordance [24]. Concordance is the agreement
of the direction of change obtained from paired mea-
surements of both the test and the reference method.
The concordance was assessed by plotting the test ΔCO
against the reference ΔCO on a four-quadrant scatter
plot. The concordance rate is the percentage of the num-
ber of data points lying in the upper right and the lower
left quadrant of the scatter plot in relation to the total
number of data points. Data at the center of the plot
represent only small and random changes in CO and
hence were excluded from the analysis (exclusion zone).
Figure 1 Flow chart of the included patients.
Table 1 Demographic and biometric data
Gender, female/male 16/4
Age, years 45 ± 8
Height, cm 171 ± 7
Weight, kg 74 ± 12
BSA, m² 1.86 ± 0.16
Time of onset of vasospasm, days (median/range) 5 (3 to 13)
Hunt and Hess grade (median/range) 4 (2 to 5)
Therapeutic procedure, clipping/coiling 15/5
Data are presented as mean ± SD if not otherwise indicated. BSA, body
surface area.
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Critchley et al., in the present study we used an exclusion
zone of 15%, and sufficient concordance to assume inter-
changeability was set to >90 to 95% [16].
Last, we applied the polar plot technique to analyzed
trending ability as recently described in detail by Critchley
et al. [16]. Briefly, the four-quadrant plot as used in the
concordance analysis presents the ΔCO data as a cartesian
(x, y) vector that has both direction and magnitude. By
converting the x-y values to polar coordinates, a new polar
plot can be drawn that shows agreement as the angle θ
(angle made by ΔCO vector with the line of identity
(y = x)) against the mean change in CO as the radian
(distance of the data point from the center of the
polar plot). The better the agreement between CO
measurements, the closer the data pairs will lie along the
horizontal radial axis (that is, within 10% of mean CO,
limits of agreement).
Results
A total of 20 patients were included in this study (Figure 1).
Demographic and biometric data of the included patients
are presented in Table 1. Hemodynamic data obtained at
each time point are depicted in Table 2. Except for MAP at
T48, there were no significant changes during the observa-
tion period.
From the 20 patients included, a total of 136 sets of CO
measurements were available for comparison of TPCO
and PCCO. Due to technical problems, CO data pairs
were available only for the first 24 hours in one patient,
and in two patients only for the first 48 hours. TPCO
ranged from 5.2 to 14.3 l · min-1 and PCCO ranged from
5.0 to 14.4 l · min-1 (Table 3).Linear correlation analysis showed acceptable correl-
ation between TPCO and PCCO only for absolute values
(Figure 2). The correlation for the percentage changes in
CO between each time point was poor (Figure 3).
A detailed statistical analysis of the comparison of
TPCO and PCCO measurements is shown in Table 3,
including the precision of the reference technique. For
all data pairs, Bland-Altman analysis revealed a bias
of −0.03 ± 0.82 l · min-1 and a limit of agreement of
1.62 l · min-1 (Figure 4), resulting in an overall percent-
age error of 18.8%. The precision of all PCCO measure-
ments was 17.8% (Table 3).
Linear correlation analysis revealed no correlation be-
tween the bias between TPCO-PCCO and SVR (Figure 5).
Trending ability of PCCO as analyzed by the concord-
ance method is shown in Figure 6. It reveals a concord-
ance rate of 74% with an exclusion zone of 15%.
Without applying an exclusion zone the concordance
decreased to 67%. Figure 7 shows the results of polar-
plot analysis. In our study (mean CO = 8.6 l min-1) only
Table 2 Hemodynamic data
T0 T2 T6 T12 T24 T48 T72
Heart rate, min-1 89 ± 17 88 ± 19 89 ± 19 86 ± 20 88 ± 17 84 ± 15 88 ± 16
MAP, mmHg 106 ± 14 106 ± 11 104 ± 14 106 ± 12 110 ± 13 114 ± 13* 112 ± 13
CVP, mmHg 12 ± 4 12 ± 3 13 ± 4 11 ± 4 12 ± 6 13 ± 3 12 ± 4
ITBV, ml 1638 ± 330 1711 ± 405 1703 ± 391 1708 ± 301 1682 ± 311 1739 ± 359 1755 ± 338
SVR, dyn s cm-5 923 ± 295 902 ± 249 891 ± 207 926 ± 209 980 ± 249 1016 ± 251 973 ± 237
ICP, mmHg 7 ± 4 8 ± 4 7 ± 3 9 ± 3 8 ± 5 8 ± 4 6 ± 4
Blood flow velocity, cm s-1
(median/range)
ICA right 63 (22 to 100) 74 (31 to 145) 68 (30 to 185) 60 (20 to 129)
ICA left 75 (33 to 101) 68 (35 to 147) 77 (33 to 200) 66 (20 to 145)
MCA right 129 (45 to 185) 137 (51 to 223) 126 (40 to 211) 114 (43 to 164)
MCA left 110 (27 to 224) 134 (61 to 280) 140 (76 to 224) 129 (35 to 272)
Hemoglobin, g l-1 11.2 ± 1.1 11.1 ± 1.1 11.1 ± 1.3 11.0 ± 1.4 11.5 ± 1.3 11.2 ± 1.3 10.7 ± 1.5
Norepinephrine, μg kg-1 min-1 0.61 ± 0.51 0.59 ± 0.52 0.64 ± 0.61 0.69 ± 0.82 0.66 ± 0.79 0.49 ± 0.44 0.44 ± 0.35
Data are presented as mean ± SD if not stated otherwise. MAP, mean arterial pressure; CVP, central venous pressure; ITBI, intrathoracic blood volume index; SVRI,
systemic vascular resistance index; ICP, intracranial pressure; ICA, internal carotid artery; MCA, middle cerebral artery.
*P <0.05 versus time (T)0.
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poor trending ability.
PCCO measurements using the PiCCO technology is
a well-established and increasingly popular method of
minimally invasive hemodynamic monitoring. The valid-
ity of PCCO measurements has been studied extensively
[3,5,6,9]. However, most of these validation studies have
been performed in cardiac surgical patients requiring
only low-to-moderate doses of vasoactive support [3,5,6,9].
In contrast we analyzed the validity and accuracy of PCCO
measurements in a setting outside of cardiac surgery and
as recently demanded [31], in a select patient group under
extreme cardiocirculatory conditions, that is, in neurosur-
gical patients requiring high-dose vasopressor support for
the prevention/treatment of DCI due to SAH.
The results of our study demonstrate that in this pa-
tient population, CO measurements by calibrated arterial
pulse-contour analysis revealed a percentage error of ap-
proximately 20% for agreement with the reference technique.Table 3 Statistical analysis of pulse wave-derived cardiac out
T0 T2 T6
TPCO, l · min-1 8.8 ± 2.4 8.8 ± 2.1 8.6 ± 2.0
CV TPCO, % 2.2 2.1 2.5
CE TPCO, % 1.2 1.2 1.4
Precision TPCO, % 2.4 2.4 2.7
PCCO, l min-1 8.8 ± 2.4 8.8 ± 2.5 8.6 ± 2.0
Bias, l min-1 0.0 ± 0.4 0.1 ± 0.9 0.0 ± 0.7
Limits of agreement, l min-1 0.9 1.8 1.4
PE PCCO, % 9.9 20.0 16.1
Precision PCCO, % 8.9 19.6 15.3
Data are presented as mean ± SD if not stated otherwise. T, time; TPCO, transpulmo
of variation; CE, coefficient of error; PE, percentage error.Likewise, detailed statistical analysis demonstrated the preci-
sion of PCCO measurements to be below 20%. These results
allow the consideration of the technology of PCCO measure-
ments as clinically interchangeable with the reference tech-
nique, at least in this specified patient population.
Discussion
Until today there is no consensus on the most appropriate
statistical methodology for the validation of continuous CO
monitoring-techniques [32]. In the first step, we used the
method introduced by Critchley and Critchley [11] for the
analysis of the agreement between PCCO measurements
and TPCO as the reference technique. These authors ori-
ginally suggested that the alternative method should have
an equivalent precision to the chosen reference method to
postulate interchangeability of the two methods. Critchley
and Critchley proposed that the reference method has to
yield a precision of approximately 20%. Hence (see also
Equation 4 in Materials and methods), the percentage errorput measurements and of the reference technique
T12 T24 T48 T72 Tall
8.6 ± 1.9 8.3 ± 1.8 8.3 ± 1.7 8.6 ± 2.0 8.5 ± 2.0
2.0 2.1 3.0 2.4 2.3
1.1 1.2 1.6 1.2 1.3
2.2 2.3 3.3 2.5 2.6
8.7 ± 2.0 8.3 ± 1.5 8.7 ± 1.8 8.6 ± 2.3 8.6 ± 2.0
-0.1 ± 0.9 0.1 ± 0.7 -0.4 ± 0.9 -0.1 ± 0.9 -0.03 ± 0.8
1.8 1.4 1.8 1.7 1.6
20.5 17.2 21.8 19.8 18.4
20.2 16.7 20.9 19.2 17.8
nary cardiac output; PCCO, pulse wave-derived cardiac output; CV, coefficient
R = 0.915,  R
2
 = 0.837, p < 0.001
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Figure 2 Linear correlation analysis of the relationship between transpulmonary thermodilution cardiac output (TPCO) and
pulse-contour derived cardiac output (PCCO) for all data.
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(or, as suggested by several authors, <30%).
As recently discussed, the rigid application of the ±30%
cutoff for the percentage error can potentially hide im-
portant information as two separate levels of precision
contribute to it, of which only the combination adds up to
the cutoff value [12,25]. Hence, a true interpretation of
the total percentage error is only possible if the precision
of each method is reported separately. In our study, both
the precision of the TPCO (<3%) and the PCCO measure-
ments (<18%) was lower than the precision of 20% asFigure 3 Linear correlation analysis of the relationship between the per
cardiac output (TPCO) and the changes indicated by pulse-contour derioriginally suggested by Critchley and Critchley, resulting
in an overall percentage error <20%.
Analyzing the trending accuracy of the test method
compared with the reference method revealed a con-
cordance rate of 74% with a 15% exclusion zone. Accord-
ing to a recent overview by Critchley et al. [16], hence, the
trending ability of the PCCO measurement can be consid-
ered poor. Because there is no consensus on an appropri-
ate exclusion zone, and several different exclusion zones
have been applied in the literature [14,23,33,34], we also
performed the concordance analysis using exclusion zonescentile changes as registered by transpulmonary thermodilution
ved cardiac output (PCCO) measurements between each time point.
Mean + 1.96 SD
Mean
Mean - 1.96 SD
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CO mean  [l.min-1]
Figure 4 Bland-Altman analysis for cardiac output (CO) measurements by transpulmonary thermodilution cardiac output (TPCO) and
by pulse-contour derived cardiac output (PCCO) for all data. Limit of agreement (LOA) is defined as the difference between the upper and
the lower level of the limits of agreement (−1.64 − 1.58 l · min-1). LOA. PE, percentage error.
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sion of substantially more data points into the analysis.
However, narrowing the exclusion zone did not result in
an improvement of concordance as expressed by concord-
ance rates of 67%, 68% and 63%, most probably due to the
fact that by this approach more central data points, and
hence, more statistical noise, were included in the analysis.
It has to be noted that the spread of percentage changes
also affects the concordance rate. In our study, the majority
of ΔCO values were rather small, which may have resultedFigure 5 Linear correlation analysis of the relationship between syste
cardiac output (TPCO)-pulse-contour derived cardiac output (PCCO) fin skewed distribution of the data points and might be
associated with false estimation of the concordance rate.
Therefore, we additionally performed a polar-plot analysis
as recently suggested by Critchley et al. [16] that allows us
to account for both the magnitude of the underlying CO
changes and the degree of agreement. Also this analysis
yielded an insufficient trending ability for the PCCO
technique.
Owing to the underlying calculation algorithms, PCCO
monitors have to be regularly recalibrated to obtain strokemic vascular resistance (SVR) and transpulmonary thermodilution
or all data.
Figure 6 Concordance rates with and without the exclusion zone of 15%. TPCO, transpulmonary thermodilution cardiac output; PCCO,
pulse-contour derived cardiac output.
Metzelder et al. Critical Care 2014, 18:R25 Page 8 of 10
http://ccforum.com/content/18/1/R25volume by an independent reference method [35-37].
However, as yet no consensus exists on the appropriate re-
calibration intervals for different patient populations. In
our study, no major changes in either cardiac preload (as
reflected by ITBV) or vascular tone (as roughly reflected
by SVR) occurred throughout the observation period. In
this situation, even recalibration intervals of up to 24 hours
were not associated with a significant loss of accuracy for
PCCO measurements. On the other hand, it is well-known
that PCCO measurements in situations of hemodynamicFigure 7 Polar plot with a 10% band as the limit of good
agreement. CO, cardiac output.instability with acute changes of vascular tone are often un-
reliable unless short recalibration intervals down to 1 hour
are employed [35-37]. Of note, more frequent recalibrations
also allow updating of relevant hemodynamic information
drawn from other thermodilution-derived variables [38].
Another interesting finding of our study was that the
accuracy of PCCO measurements was not influenced by
SVR, which is in contrast to the cardiac output measure-
ments derived by auto-calibrating pulse-contour ana-
lysis, as recently reported by us using the same study
design, and by other groups [20-22,25].
The present study has several limitations. Only a
highly selected patient-collective was included in the
study, so that extrapolation of the results to other pa-
tient populations is hardly possible. Moreover, all of our
patients exhibited normal to supranormal cardiac out-
puts. The accuracy of PCCO measurements in patients
with low cardiac outputs could therefore, not be analyzed
and remains to be investigated. Finally, despite the high-
dose vasopressor therapy all patients were in a hemo-
dynamically stable state in which no major changes of
cardiac preload or vasotonus occurred.
Conclusions
In neurosurgical patients requiring extensive vasoactive
support, CO values obtained by PCCO showed a percent-
age error of <20% for the agreement with TPCO measure-
ments as the reference technique. This error is commonly
regarded as a criterion for method interchangeability. The
precision of calibrated CO measurements was clinically
appropriate and independent of SVR. However, owing to
the poor trending ability of the PCCO device, caution is
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upon the results of the pulse-contour analysis rather than
performing frequent TPCO measurements.
Key messages
 In patients requiring extensive vasoactive support
for the treatment of DCI, PCCO measurements
showed a percentage error <20% to show agreement
with the reference technique.
 In comparison to TPCO, the precision of PCCO
measurements was appropriate.
 The accuracy of PCCO measurements was
independent of systemic vascular resistance.
 In our patients, PCCO measurements did not
reliably track CO changes.
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